Akker et al. recently demonstrated an increase in insulin resistance in patients with differentiated thyroid cancer [11], however, consistent with the hypothesis that diabetes increases the risk of thyroid cancer through hyperinsulinemia and activation of the insulin receptor or the insulin-like growth factor-I receptor. Here, IGF1R is linked to hyperinsulinism.